YU42796A - Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija - Google Patents

Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija

Info

Publication number
YU42796A
YU42796A YU42796A YU42796A YU42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A
Authority
YU
Yugoslavia
Prior art keywords
cells
ypriflavone
reduction
appropriate
preparation containing
Prior art date
Application number
YU42796A
Other languages
English (en)
Inventor
Attila Kovacs
Peter Aranyi
Tereezia Kerepesi
Attila Tar
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of YU42796A publication Critical patent/YU42796A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

Predmetni pronalazak se odnosi na farmaceutski preparat podesan za smanjenje broja CD8+ ćelija koji obuhvata kao aktivni sastojak 7-izopropoksiizoflavon u smeši sa podesnim inertnim, čvrstim ili tečnim nosačima i po izboru sa uobičajenim terapeutskim aditivima i pomoćnim agensima. Farmacetuski preparati prema pronalasku se dobivaju poznatim postupcima i podesni su za tretiranje humanih i animalnih subjekata koji su u stanju gde se želi supresija CD8+ limfocita.
YU42796A 1995-07-21 1996-07-19 Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija YU42796A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication

Publications (1)

Publication Number Publication Date
YU42796A true YU42796A (sh) 1999-03-04

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42796A YU42796A (sh) 1995-07-21 1996-07-19 Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija

Country Status (22)

Country Link
EP (1) EP0841915A1 (sh)
JP (1) JP2001503371A (sh)
KR (1) KR19990028933A (sh)
CN (1) CN1191483A (sh)
AR (1) AR002905A1 (sh)
AU (1) AU6367096A (sh)
BG (1) BG102182A (sh)
BR (1) BR9610187A (sh)
CA (1) CA2227421A1 (sh)
CZ (1) CZ2798A3 (sh)
EA (1) EA199800146A1 (sh)
EE (1) EE9800020A (sh)
HR (1) HRP960345A2 (sh)
HU (1) HU9502198D0 (sh)
IL (1) IL122751A0 (sh)
MX (1) MX9800603A (sh)
NO (1) NO980127D0 (sh)
PL (1) PL324460A1 (sh)
SK (1) SK3298A3 (sh)
WO (1) WO1997003664A1 (sh)
YU (1) YU42796A (sh)
ZA (1) ZA966079B (sh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
AR002905A1 (es) 1998-04-29
EE9800020A (et) 1998-08-17
SK3298A3 (en) 1998-07-08
KR19990028933A (ko) 1999-04-15
AU6367096A (en) 1997-02-18
EP0841915A1 (en) 1998-05-20
CZ2798A3 (cs) 1998-06-17
CA2227421A1 (en) 1997-02-06
MX9800603A (es) 1998-04-30
BG102182A (en) 1998-08-31
IL122751A0 (en) 1998-08-16
NO980127L (no) 1998-01-12
JP2001503371A (ja) 2001-03-13
HU9502198D0 (en) 1995-09-28
PL324460A1 (en) 1998-05-25
ZA966079B (en) 1998-01-19
EA199800146A1 (ru) 1998-08-27
BR9610187A (pt) 1998-07-28
WO1997003664A1 (en) 1997-02-06
NO980127D0 (no) 1998-01-12
HRP960345A2 (en) 1998-02-28
CN1191483A (zh) 1998-08-26
WO1997003664A8 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
NO20005431L (no) Gelerbare farmasoytiske preparater
DE60236611D1 (de) Zahnpflegezusammensetzungen
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
ATE215827T1 (de) Immunologische aktivität der rhamnolipide
MD1688G2 (ro) Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie .
DK284386D0 (da) Farmaceutisk praeparat mod hudlidelser
DE69805983D1 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES8400076A1 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
DE69632396D1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
KR880007068A (ko) 13-시스 레티노산의 용도
YU42796A (sh) Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija
HRP20060040A2 (en) PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS
DK0981363T3 (da) Somatostatinagonister til reduktion af legemsvægt
IT1172264B (it) Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo
KR20040049068A (ko) 모발 성장 촉진제 조성물
WO1988007371A3 (en) Prevention and treatment of the deleterious effects of exposing skin to the sun, and compositions therefor
JPS61286327A (ja) 移植皮膚処置剤
ES2122010T3 (es) Muteinas de amilina.